S.1521 - Gabriella Miller Kids First Research Act 2.0117th Congress (2021-2022) |
|Sponsor:||Sen. Kaine, Tim [D-VA] (Introduced 04/29/2021)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||04/29/2021 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.1521 — 117th Congress (2021-2022)All Information (Except Text)
Introduced in Senate (04/29/2021)
Gabriella Miller Kids First Research Act 2.0
This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).
Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.
This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.